GI
RGNX icon

GAMMA Investing’s Regenxbio RGNX Stock Holding History

GAMMA Investing’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$18K Buy
2,387
+105
+5% +$1.06K ﹤0.01% 3010
2026
Q2 		$27.3K Sell
2,282
-37
-2% -$307 ﹤0.01% 2676
2026
Q1 		$19.4K Buy
2,319
+126
+6% +$1.32K ﹤0.01% 2725
2025
Q4 		$31.6K Buy
2,193
+205
+10% +$2.56K ﹤0.01% 2358
2025
Q3 		$19.2K Sell
1,988
-943
-32% -$8.34K ﹤0.01% 2533
2025
Q2 		$24.1K Buy
2,931
+667
+29% +$5.58K ﹤0.01% 2360
2025
Q1 		$16.2K Sell
2,264
-1,165
-34% -$8.67K ﹤0.01% 2504
2024
Q4 		$26.5K Buy
3,429
+2,510
+273% +$23.6K ﹤0.01% 2112
2024
Q3 		$9.64K Buy
919
+704
+327% +$8.58K ﹤0.01% 2476
2024
Q2 		$2.52K Sell
215
-360
-63% -$5.6K ﹤0.01% 2819
2024
Q1 		$12.1K Buy
575
+510
+785% +$9.07K ﹤0.01% 1950
2023
Q4 		$801 Buy
+65
New +$1.15K ﹤0.01% 2856

Other funds holding RGNX

VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
EB
Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return

GAMMA Investing's RGNX Position: Q3 2026 in Review

GAMMA Investing increased its Regenxbio (RGNX) stake by 4.6% in Q3 2026, buying an estimated $1.06K and bringing the position to 2,387 shares worth $18K. The position accounts for ﹤0.01% of the portfolio, ranked #3010.

GAMMA Investing first reported a position in RGNX in Q4 2023 and has held it in 12 quarters since. The position peaked at $31.6K in Q4 2025. 4 funds tracked by Wall St. Rank hold RGNX as of Q3 2026.

  • GAMMA Investing held 2,387 shares of Regenxbio worth $18K as of Q3 2026.
  • GAMMA Investing bought 105 Regenxbio shares in Q3 2026, an estimated $1.06K.
  • Regenxbio made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #3010 holding.
  • GAMMA Investing first reported a position in Regenxbio in Q4 2023 and has held it in 12 quarters since.
  • GAMMA Investing's Regenxbio position peaked at $31.6K in Q4 2025.
  • 4 funds tracked by Wall St. Rank held Regenxbio as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.